Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
Hlavní autoři: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2018
|
Podobné jednotky
-
Modeling Fragile X Syndrome in Drosophila
Autor: Małgorzata Drozd, a další
Vydáno: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
Autor: Alessandra Tempio, a další
Vydáno: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
Autor: Thomas Maurin, a další
Vydáno: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
Autor: Tovi Anderson, a další
Vydáno: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
Autor: Sara Castagnola, a další
Vydáno: (2017-11-01)